Summary of Study ST000061
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000058. The data can be accessed directly via it's Project DOI: 10.21228/M80018 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000061 |
Study Title | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: GC-TOF MS analyis of subcutaneous and visceral adipose tissue samples |
Study Type | biomarker study |
Study Summary | This West Coast Metabolomics Center pilot and feasibility project was granted to Johanna Lampe (Fred Hutchinson Cancer Research Center at Univ. of Washington, Seattle). In the current investigation, unbiased profiling of the metabolome and lipidome of adipose tissue samples (visceral(VAT) and subcutaenous (SAT)) and serum of 50 CRC patients, including stages I-IV, from the Fred Hutchinson Cancer Center (Seattle,WA) and the German Cancer Research Center (Heidelberg, Germany) was conducted. The lipidome and metabolome of adipose tissue (VAT/SAT) and serum were analyzed using established UPLC-QTOFMS analysis and GC-TOFMS analyses, respectively. The primary objectives of this project were to 1) compare the metabolome and lipidome of matched VAT and SAT adipose tissue of n=50 Colorectal Cancer Cell (CRC) patients, 2) characterize the associations between the lipidome and metabolome in adipose tissue (VAT/SAT) and serum of n=50 CRC patients and 3) test the associations between the lipidome/metabolome of VAT and serum with the tumor stage of CRC patients. |
Institute | University of California, Davis |
Department | Genome and Biomedical Sciences Facility |
Laboratory | WCMC Metabolomics Core |
Last Name | Fiehn |
First Name | Oliver |
Address | 1315 Genome and Biomedical Sciences Facility 451 Health Sciences Drive Davis, CA 95616 |
ofiehn@ucdavis.edu | |
Phone | (530) 754-8258 |
Submit Date | 2014-06-11 |
Num Groups | 3 |
Total Subjects | 130 |
Study Comments | 2014-03-05 17:49:16.898 |
Raw Data Available | Yes |
Raw Data File Type(s) | cdf |
Uploaded File Size | 5.4 G |
Analysis Type Detail | GC-MS |
Release Date | 2014-07-11 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000058 |
Project DOI: | doi: 10.21228/M80018 |
Project Title: | Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: Unraveling the Link Between Adipose Tissue and Cancer |
Project Type: | biomarker study |
Project Summary: | This West Coast Metabolomics Center pilot and feasibility project was granted to Johanna Lampe (Fred Hutchinson Cancer Research Center at Univ. of Washington, Seattle). In the current investigation, unbiased profiling of the metabolome and lipidome of adipose tissue samples (visceral(VAT) and subcutaenous (SAT)) and serum of 50 CRC patients, including stages I-IV, from the Fred Hutchinson Cancer Center (Seattle,WA) and the German Cancer Research Center (Heidelberg, Germany) was conducted. The lipidome and metabolome of adipose tissue (VAT/SAT) and serum were analyzed using established UPLC-QTOFMS analysis and GC-TOFMS analyses, respectively. The primary objectives of this project were to 1) compare the metabolome and lipidome of matched VAT and SAT adipose tissue of n=50 Colorectal Cancer Cell (CRC) patients, 2) characterize the associations between the lipidome and metabolome in adipose tissue (VAT/SAT) and serum of n=50 CRC patients and 3) test the associations between the lipidome/metabolome of VAT and serum with the tumor stage of CRC patients. |
Institute: | University of California, Davis |
Department: | Genome and Biomedical Sciences Facility |
Laboratory: | WCMC Metabolomics Core |
Last Name: | Fiehn |
First Name: | Oliver |
Address: | 1315 Genome and Biomedical Sciences Facility,451 Health Sciences Drive, Davis, CA 95616 |
Email: | ofiehn@ucdavis.edu |
Phone: | (530) 754-8258 |
Funding Source: | NIH U24DK097154 |
Subject:
Subject ID: | SU000080 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Human |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Source |
---|---|---|
SA003106 | SAT_10 | Group 1 - Subcutaenous Fat |
SA003107 | SAT_28 | Group 1 - Subcutaenous Fat |
SA003108 | SAT_25 | Group 1 - Subcutaenous Fat |
SA003109 | SAT_15 | Group 1 - Subcutaenous Fat |
SA003110 | SAT_51 | Group 1 - Subcutaenous Fat |
SA003111 | SAT_21 | Group 1 - Subcutaenous Fat |
SA003112 | SAT_44 | Group 1 - Subcutaenous Fat |
SA003113 | SAT_48 | Group 1 - Subcutaenous Fat |
SA003114 | SAT_43 | Group 1 - Subcutaenous Fat |
SA003115 | SAT_8 | Group 1 - Subcutaenous Fat |
SA003116 | SAT_35 | Group 1 - Subcutaenous Fat |
SA003117 | SAT_45 | Group 1 - Subcutaenous Fat |
SA003118 | SAT_36 | Group 1 - Subcutaenous Fat |
SA003119 | SAT_11 | Group 1 - Subcutaenous Fat |
SA003120 | SAT_31 | Group 1 - Subcutaenous Fat |
SA003121 | SAT_52 | Group 1 - Subcutaenous Fat |
SA003122 | SAT_13 | Group 1 - Subcutaenous Fat |
SA003123 | SAT_41 | Group 1 - Subcutaenous Fat |
SA003124 | SAT_54 | Group 1 - Subcutaenous Fat |
SA003125 | SAT_22 | Group 1 - Subcutaenous Fat |
SA003126 | SAT_3 | Group 1 - Subcutaenous Fat |
SA003127 | SAT_49 | Group 1 - Subcutaenous Fat |
SA003128 | SAT_37 | Group 1 - Subcutaenous Fat |
SA003129 | SAT_23 | Group 1 - Subcutaenous Fat |
SA003130 | SAT_40 | Group 1 - Subcutaenous Fat |
SA003131 | SAT_27 | Group 1 - Subcutaenous Fat |
SA003132 | SAT_53 | Group 1 - Subcutaenous Fat |
SA003133 | SAT_20 | Group 1 - Subcutaenous Fat |
SA003134 | SAT_16 | Group 1 - Subcutaenous Fat |
SA003135 | SAT_58 | Group 1 - Subcutaenous Fat |
SA003136 | SAT_34 | Group 1 - Subcutaenous Fat |
SA003137 | SAT_1 | Group 1 - Subcutaenous Fat |
SA003138 | SAT_24 | Group 1 - Subcutaenous Fat |
SA003139 | SAT_55 | Group 1 - Subcutaenous Fat |
SA003140 | SAT_17 | Group 1 - Subcutaenous Fat |
SA003141 | SAT_46 | Group 1 - Subcutaenous Fat |
SA003142 | SAT_6 | Group 1 - Subcutaenous Fat |
SA003143 | SAT_29 | Group 1 - Subcutaenous Fat |
SA003144 | SAT_4 | Group 1 - Subcutaenous Fat |
SA003145 | SAT_2 | Group 1 - Subcutaenous Fat |
SA003146 | SAT_12 | Group 1 - Subcutaenous Fat |
SA003147 | SAT_56 | Group 1 - Subcutaenous Fat |
SA003148 | SAT_33 | Group 1 - Subcutaenous Fat |
SA003149 | SAT_30 | Group 1 - Subcutaenous Fat |
SA003150 | SAT_26 | Group 1 - Subcutaenous Fat |
SA003151 | SAT_38 | Group 1 - Subcutaenous Fat |
SA003152 | SAT_9 | Group 1 - Subcutaenous Fat |
SA003153 | SAT_18 | Group 1 - Subcutaenous Fat |
SA003154 | SAT_32 | Group 1 - Subcutaenous Fat |
SA003155 | SAT_14 | Group 1 - Subcutaenous Fat |
SA003156 | SAT_47 | Group 1 - Subcutaenous Fat |
SA003157 | SAT_50 | Group 1 - Subcutaenous Fat |
SA003158 | SAT_19 | Group 1 - Subcutaenous Fat |
SA003159 | SAT_5 | Group 1 - Subcutaenous Fat |
SA003160 | SAT_57 | Group 1 - Subcutaenous Fat |
SA003161 | SAT_39 | Group 1 - Subcutaenous Fat |
SA003162 | SAT_7 | Group 1 - Subcutaenous Fat |
SA003163 | SAT_42 | Group 1 - Subcutaenous Fat |
SA003164 | SAT_59 | Group 1 - Subcutaenous Fat |
SA003165 | VAT__35 | Group 2 - Visceral Fat |
SA003166 | VAT__8 | Group 2 - Visceral Fat |
SA003167 | VAT__49 | Group 2 - Visceral Fat |
SA003168 | VAT__34 | Group 2 - Visceral Fat |
SA003169 | VAT__42 | Group 2 - Visceral Fat |
SA003170 | VAT__10 | Group 2 - Visceral Fat |
SA003171 | VAT__15 | Group 2 - Visceral Fat |
SA003172 | VAT__17 | Group 2 - Visceral Fat |
SA003173 | VAT__50 | Group 2 - Visceral Fat |
SA003174 | VAT__52 | Group 2 - Visceral Fat |
SA003175 | VAT__39 | Group 2 - Visceral Fat |
SA003176 | VAT__4 | Group 2 - Visceral Fat |
SA003177 | VAT__48 | Group 2 - Visceral Fat |
SA003178 | VAT__19 | Group 2 - Visceral Fat |
SA003179 | VAT__41 | Group 2 - Visceral Fat |
SA003180 | VAT__16 | Group 2 - Visceral Fat |
SA003181 | VAT__24 | Group 2 - Visceral Fat |
SA003182 | VAT__6 | Group 2 - Visceral Fat |
SA003183 | VAT__23 | Group 2 - Visceral Fat |
SA003184 | VAT__3 | Group 2 - Visceral Fat |
SA003185 | VAT__47 | Group 2 - Visceral Fat |
SA003186 | VAT__31 | Group 2 - Visceral Fat |
SA003187 | VAT__36 | Group 2 - Visceral Fat |
SA003188 | VAT__40 | Group 2 - Visceral Fat |
SA003189 | VAT__37 | Group 2 - Visceral Fat |
SA003190 | VAT__46 | Group 2 - Visceral Fat |
SA003191 | VAT__5 | Group 2 - Visceral Fat |
SA003192 | VAT__56 | Group 2 - Visceral Fat |
SA003193 | VAT__13 | Group 2 - Visceral Fat |
SA003194 | VAT__44 | Group 2 - Visceral Fat |
SA003195 | VAT__58 | Group 2 - Visceral Fat |
SA003196 | VAT__54 | Group 2 - Visceral Fat |
SA003197 | VAT__11 | Group 2 - Visceral Fat |
SA003198 | VAT__51 | Group 2 - Visceral Fat |
SA003199 | VAT__12 | Group 2 - Visceral Fat |
SA003200 | VAT__43 | Group 2 - Visceral Fat |
SA003201 | VAT__45 | Group 2 - Visceral Fat |
SA003202 | VAT__29 | Group 2 - Visceral Fat |
SA003203 | VAT__30 | Group 2 - Visceral Fat |
SA003204 | VAT__32 | Group 2 - Visceral Fat |
SA003205 | VAT__9 | Group 2 - Visceral Fat |
Collection:
Collection ID: | CO000063 |
Collection Summary: | - |
Sample Type: | Adipose tissue |
Treatment:
Treatment ID: | TR000081 |
Treatment Protocol Filename: | Protocol_for_primary_metabolites_lampe_trial_1_0214.docx |
Treatment Protocol Comments: | Protocoll-changes.docx |
Sample Preparation:
Sampleprep ID: | SP000076 |
Sampleprep Summary: | - |
Sampleprep Protocol Filename: | Data_Dictionary_Fiehn_laboratory_GCTOF_MS_primary_metabolism_10-15-2013_general.pdf |
Sample Spiking: | FAMEs |
Combined analysis:
Analysis ID | AN000099 |
---|---|
Analysis type | MS |
Chromatography type | GC |
Chromatography system | Agilent 6890N |
Column | Restek Corporation Rtx-5Sil MS |
MS Type | EI |
MS instrument type | GC-TOF |
MS instrument name | Leco GC-TOF |
Ion Mode | POSITIVE |
Units | Peak area |
Chromatography:
Chromatography ID: | CH000067 |
Methods Filename: | Data_Dictionary_Fiehn_laboratory_GCTOF_MS_primary_metabolism_10-15-2013_general.pdf |
Instrument Name: | Agilent 6890N |
Column Name: | Restek Corporation Rtx-5Sil MS |
Column Pressure: | 7.7 PSI (initial condition) |
Column Temperature: | 50 - 330C |
Flow Rate: | 1 ml/min |
Injection Temperature: | 50C ramped to 250C by 12C/s |
Sample Injection: | 0.5l |
Oven Temperature: | 50C for 1 min, then ramped at 20C/min to 330C, held constant for 5 min |
Transferline Temperature: | 230C |
Washing Buffer: | Ethyl Acetate |
Sample Loop Size: | 30 m length x 0.25 mm internal diameter |
Randomization Order: | Excel generated |
Chromatography Type: | GC |
MS:
MS ID: | MS000075 |
Analysis ID: | AN000099 |
Instrument Name: | Leco GC-TOF |
Instrument Type: | GC-TOF |
MS Type: | EI |
Ion Mode: | POSITIVE |
Ion Source Temperature: | 250°C |
Ionization Energy: | 70eV |
Mass Accuracy: | Nominal |
Source Temperature: | 250°C |
Scanning Range: | 80-500 Da |
Acquisition Parameters File: | Data_Dictionary_Fiehn_laboratory_GCTOF_MS_primary_metabolism_10-15-2013_general.pdf |
Processing Parameters File: | Data_Dictionary_Fiehn_laboratory_GCTOF_MS_primary_metabolism_10-15-2013_general.pdf |